Sex-Associated Radiographic and Clinical Differences in Nontuberculous Mycobacteria Pulmonary Disease.

Sex-Associated Radiographic and Clinical Differences in Nontuberculous Mycobacteria Pulmonary Disease.

Publication date: Oct 03, 2025

The incidence of infections caused by nontuberculous mycobacteria (NTM) are steadily increasing worldwide and the most common site of infection is the lung. Clinical characteristics of individuals with NTM pulmonary disease (NTM-PD) demonstrate pronounced geographical heterogeneity. In the United States, NTM-PD has an affinity for post-menopausal Caucasian females, many of whom are never-smokers, whereas in Asia NTM-PD is more common in males with post-tuberculosis lung disease. While these geographical differences are known on the global scale, it remains unclear whether radiographic sex-associated differences in NTM-PD are present within the US cohort. In this single center cross-sectional retrospective study of our patient registry, we sought to assess this knowledge gap by comparing radiographic and clinical features of individuals with NTM-PD by sex. We observed a significant preponderance of cavitary disease in men, while women commonly presented with bilateral apical fibrosis, increased nodules and tree-in-bud patterns in the lower lobes, and an increased risk of refractory disease and concomitant co-infection. Results from this study demonstrate several sex-associated differences in the radiographic phenotype of NTM-PD, and may be the result of differences in pre-existing risk factors that contribute to the development of NTM-PD. Future studies will be required to better assess the broad applicability of these findings to centers from other geographic regions where the underlying etiology of disease may vary.

Concepts Keywords
Caucasian gender bias
Menopausal lung disease
Mycobacteria
Tuberculosis
Worldwide

Semantics

Type Source Name
disease MESH Pulmonary Disease
disease MESH infections
disease IDO site of infection
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH fibrosis
disease MESH co-infection
drug DRUGBANK Tropicamide
disease MESH etiology

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *